Journal of Affective Disorders
Volume 84, Issue 2 , Pages 259-266 , February 2005

Sustained remission with lamotrigine augmentation or monotherapy in female resistant depressives with mixed cyclothymic–dysthymic temperament

  • J.Sloan Manning

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +1-336-812-9844.
    • From Mood Clinic, Family Medicine Department, University of Tennessee, Memphis, TN, USA
    • ,
  • Radwan F. Haykal

      Affiliations

    • From Mood Clinic, Family Medicine Department, University of Tennessee, Memphis, TN, USA
    • From Psychiatry Department, University of Tennessee, Memphis, TN, USA
    • ,
  • Pamela D. Connor

      Affiliations

    • From Mood Clinic, Family Medicine Department, University of Tennessee, Memphis, TN, USA
    • ,
  • Patricia D. Cunningham

      Affiliations

    • From Mood Clinic, Family Medicine Department, University of Tennessee, Memphis, TN, USA
    • ,
  • W.Clay Jackson

      Affiliations

    • From Mood Clinic, Family Medicine Department, University of Tennessee, Memphis, TN, USA
    • ,
  • Stephanie Long

      Affiliations

    • From Mood Clinic, Family Medicine Department, University of Tennessee, Memphis, TN, USA

Received 28 May 2003 ,Accepted 30 January 2004.

References 

  1. Akiskal HS. Subaffective disorders: dysthymic, cyclothymic and bipolar II disorders in the borderline realm. Psychiatr. Clin. North Am. 1981;4:25–46
  2. Akiskal HS. Delineating irritable and hyperthymic variants of the cyclothymic temperament. J. Pers. Disord. 1992;6:326–342
  3. Akiskal HS. The prevalent clinical spectrum of bipolar disorders: beyond DSM-IV. J. Clin. Psychopharmacol. 1996;16(Suppl. 1):4s–14s
  4. Akiskal HS, Pinto O. The evolving bipolar spectrum. Prototypes I, II, III, and IV. Psychiatr. Clin. North Am. 1999;22:517–534
  5. Akiskal HS, Djenderedjian AH, Rosenthal RH, Khani MK. Cyclothymic disorder: validating criteria for inclusion in the bipolar affective group. Am. J. Psychiatry. 1977;134:1227–1233
  6. Akiskal HS, Rosenthal TL, Haykal RF, Lemmi H, Rosenthal RH, Scott-Strauss A. Characterological depressions. Clinical and sleep EEG findings separating “subaffective dysthymias” from “character spectrum disorders”. Arch. Gen. Psychiatry. 1980;37:777–783
  7. Akiskal HS, Maser JD, Zeller PJ, Endicott J, Coryell W, Keller M, et al. Switching from ‘unipolar’ to bipolar II: an 11-year prospective study of clinical and temperamental predictors in 559 patients. Arch. Gen. Psychiatry. 1995;52:114–123
  8. Akiskal HS, Bourgeois ML, Angst J, Post R, Moller H, Hirschfeld R. Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders. J. Affect. Disord. 2000;59(Suppl. 1):S5–S30
  9. Akiskal HS, Hantouche EG, Lancrenon S. Bipolar II with and without cyclothymic temperament: “dark” and “sunny” expressions of soft bipolarity. J. Affect Disord. 2003;73:49–57
  10. Akiskal HS, Akiskal K, Haykal R, Manning S, Connor P. The affective temperament scales of Memphis, Pisa, Paris, and San Diego: progress towards a self-rated auto-questionnaire version (TEMP-A). J. Affect. Disord. 2005; (in press)
  11. Allilaire JF, Hantouche EG, Sechter D, Bourgeois ML, Azorin JM, Lancrenon S, et al. Frequency and clinical aspects of bipolar II disorder in a French multicenter study: EPIDEP. Encephale. 2001;27:149–158
  12. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 4th edition. Washington, DC: American Psychiatric Association; 1994;
  13. Angst J. The emerging epidemiology of hypomania and bipolar II disorder. J. Affect. Disord. 1998;50:143–151
  14. Benazzi F. Is 4 days the minimum duration of hypomania in bipolar II disorder?. Eur. Arch. Psychiatry Clin. Neurosci. 2001;251:32–34
  15. Bowden CL, Calabrese JR, McElroy SL, Rhodes LJ, Keck PE, Cookson J, et al. The efficacy of lamotrigine in rapid cycling and non-rapid cycling patients with bipolar disorder. Biol. Psychiatry. 1999;15:953–958
  16. Bowden CL, Calabrese JR, Sachs G, Yatham LN, Asghar SA, Hompland M, et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch. Gen. Psychiatry. 2003;60:392–400
  17. Calabrese JR, Fatemi SH, Woyshville MJ. Antidepressant effects of lamotrigine in rapid cycling bipolar disorder. Am. J. Psychiatry. 1996;153:1236
  18. Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 study group. J. Clin. Psychiatry. 1999;60:79–88
  19. Calabrese JR, Suppes T, Bowden CL, Sachs GS, Swann AC, McElroy SL, et al. A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 study group. J. Clin. Psychiatry. 2000;61:841–850
  20. Calabrese JR, Bowden CL, Sachs G, Yatham LN, Behnke K, Mehtonen OP, et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J. Clin. Psychiatry. 2003;64:1013–1024
  21. Coryell W, Endicott J, Maser JD, Keller MB, Leon AC, Akiskal HS. Long-term stability of polarity distinctions in the affective disorders. Am. J. Psychiatry. 1995;152:385–390
  22. Frankenburg FR, Zanarini MC. Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: a double blind placebo-controlled study. J. Clin. Psychiatry. 2002;63:442–446
  23. Haykal RF, Akiskal HS. The long-term outcome of dysthymia: clinical features, temperament, and the art of management. J. Clin. Psychiatry. 1999;60:508–518
  24. Hirschfeld RM, Lewis L, Vornik LA. Perceptions and impact of bipolar disorder: how far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder. J. Clin. Psychiatry. 2003;64:161–174
  25. Ichim L, Berk M, Brook S. Lamotrigine compared with lithium in mania: a double-blind randomized controlled trial. Ann. Clin. Psychiatry. 2000;12:5–10
  26. Judd LL, Akiskal HS. The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases. J. Affect Disord. 2003;73:123–131
  27. Koukopoulos A, Koukopoulos A. Agitated depression as a mixed state and the problem of melancholia. Psychiatr. Clin. North Am. 1999;22:547–564
  28. Kraepelin E. Manic-Depressive Insanity and Paranoia. Edinburgh: Livingstone; 1899/1921;
  29. Kretschmer E. Physique and Character. London: Degan, Paul, Trench, Trubner; 1936;
  30. Manning JS, Haykal RF, Connor PD, Akiskal HS. On the nature of depressed and anxious states in a family practice setting: the high prevalence of bipolar II and related disorders in a cohort followed longitudinally. Compr. Psychiatry. 1997;38:102–108
  31. Manning JS, Zylstra RG, Connor PD. Teaching family physicians about mood disorders: a procedure suite for behavioral medicine. Prim. Care Companion J. Clin. Psychiat. 1999;1:18–23
  32. Perugi G, Musetti L, Simonini E, Piagentini F, Cassano GB, Akiskal HS. Gender mediated clinical features of depressive illness: the importance of temperamental differences. Br. J. Psychiatry. 1990;157:835–841
  33. Pinto OC, Akiskal HS. Lamotrigine as a promising approach to borderline personality: an open case series without concurrent DSM-IV major mood disorder. J. Affect. Disord. 1998;51:333–343
  34. Regier DA, Narrow WE, Rae DS, Manderscheid RW, Locke BZ, Goodwin FK. The de facto mental and addictive disorders service system: epidemiologic catchment area prospective 1-year prevalence rates of disorders and services. Arch. Gen. Psychiatry. 1993;50:85–94
  35. Souery D, Amsterdam J, de Montigny C, Lecrubier Y, Montgomery S, Lipp O, et al. Treatment resistant depression: methodological overview and operational criteria. Eur. Neuropsychopharmacol. 1999;9:83–91
  36. Wicki W, Angst J. The Zurich study: X. hypomania in a 28- to 30-year old cohort. Eur. Arch. Psychiatry Clin. Neurosci. 1991;240:339–348

PII: S0165-0327(04)00087-4

doi: 10.1016/j.jad.2004.01.016

Journal of Affective Disorders
Volume 84, Issue 2 , Pages 259-266 , February 2005

Article Tools